Gibbons Christopher H, Goebel-Fabbri Ann
Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Palmer 111, Boston, MA, 02215, USA.
, 1101 Beacon St. 8W, Brookline, MA, 02446, USA.
Curr Diab Rep. 2017 Jul;17(7):48. doi: 10.1007/s11892-017-0880-5.
Aggressive glycemic control has become the standard clinical approach to diabetes care. Unintended consequences have included the development of microvascular complications that are related to the rapidity of glycemic improvement.
Diabetic neuropathy may develop in up to 10% of individuals secondary to aggressive glycemic control. The neuropathy is predominantly small fiber sensory and autonomic, and the severity of the neuropathy is tied to the change in the glycosylated hemoglobin A1C. Other microvascular complications such as retinopathy and nephropathy are common and may occur in parallel with the neuropathy. Eating disorders are a common comorbid risk factor. Individuals with uncontrolled diabetes for prolonged periods, particularly those with a history of eating disorders involving insulin restriction for calorie purging, are at high risk for developing treatment-induced microvascular complications. Gradual glycemic improvements should be encouraged but future research is needed to optimize treatment and prevention strategies.
强化血糖控制已成为糖尿病治疗的标准临床方法。意外后果包括与血糖改善速度相关的微血管并发症的发生。
高达10%的个体在强化血糖控制后可能会发生糖尿病神经病变。这种神经病变主要是小纤维感觉和自主神经病变,神经病变的严重程度与糖化血红蛋白A1C的变化有关。其他微血管并发症,如视网膜病变和肾病也很常见,可能与神经病变同时发生。饮食失调是常见的合并危险因素。长期糖尿病控制不佳的个体,尤其是那些有通过限制胰岛素摄入以控制热量摄入的饮食失调史的个体,发生治疗诱导的微血管并发症的风险很高。应鼓励逐步改善血糖,但需要未来的研究来优化治疗和预防策略。